We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

566:SGXSHS Holdings Ltd. Analysis

Data as of 2026-07-25 - not real-time

SGD 0.12

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The share price is hugging its short‑term moving average and sits just above a well‑defined support zone while approaching a modest resistance level. Momentum indicators are neutral to mildly bullish, with the relative strength index lingering in the mid‑fifties and the MACD line just nudging above its signal, supported by an increasing volume trend. Volatility remains elevated, suggesting sizable price swings, yet the beta is slightly negative, indicating limited correlation with broader market moves.
Fundamental perspective: Revenue growth is modest and margins are in the red, resulting in negative earnings and a return on equity that is below zero. The balance sheet shows cash slightly trailing total debt, and the debt‑to‑equity ratio is moderate. However, the price‑to‑book multiple is well under one and the discounted cash‑flow model points to a fair value that is considerably higher than the current market price, implying a sizable discount. The dividend yield is modest but the payout ratio is high relative to earnings, raising questions about sustainability. Overall, the stock appears undervalued on a value basis, but earnings weakness and financial leverage temper the upside.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price is near a key support level
  • high short‑term volatility
  • negative earnings and margins

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • significant discount to DCF fair value
  • moderate dividend yield
  • potential improvement in cash flow

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • underlying demand for corrosion‑prevention services
  • growth opportunities in solar‑energy projects
  • value‑oriented pricing relative to book

Key Metrics & Analysis

Financial Health

Revenue Growth323.70%
Profit Margin-4.99%
ROE-9.37%
ROA-3.22%
Debt/Equity50.48
P/B Ratio0.5
Op. Cash FlowSGD7.2M
Free Cash FlowSGD35.0M
Industry P/E31.4

Technical Analysis

TrendNeutral
RSI54.7
SupportSGD 0.11
ResistanceSGD 0.12
MA 20SGD 0.12
MA 50SGD 0.12
MA 200SGD 0.12
MACDBullish
VolumeIncreasing
Fear & Greed Index88.25

Valuation

Fair ValueSGD 1.99
GradeUndervalued
TypeValue
Dividend Yield2.03%

Risk Assessment

Beta-0.10
Volatility45.97%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.